Doxycycline inhibits vascular leakage and prevents ovarian hyperstimulation syndrome in a murine model

Fertility and Sterility

Volumn 92, Issue 5, 2009, Pages 1701-1705

  Fainaru, Ofer ^a,b   Hornstein, Mark D ^b   Folkman, Judah ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

angiogenesis; doxycycline; Ovarian hyperstimulation syndrome

Indexed keywords

CHORIONIC GONADOTROPIN; DOXYCYCLINE; DRUG VEHICLE; DYE; GONADOTROPIN;

ABDOMINAL WALL; ANIMAL MODEL; ARTICLE; ASCITES; BLOOD VESSEL; BLOOD VESSEL PERMEABILITY; CAPILLARY LEAK SYNDROME; CONTROLLED STUDY; CORPUS LUTEUM; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INHIBITION; DRUG MEGADOSE; DYE DILUTION CURVE; FEMALE; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; ORGAN WEIGHT; OVARY; OVARY HYPERSTIMULATION; OVULATION; PERITONEAL CAPILLARY LEAKAGE; PERITONEAL FLUID; PERITONEUM LAVAGE; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

ANIMALS; ASCITES; CAPILLARY PERMEABILITY; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DOXYCYCLINE; DRUG COMBINATIONS; DRUG EVALUATION, PRECLINICAL; EDEMA; FEMALE; GONADOTROPINS; MICE; MICE, INBRED C57BL; OVARIAN HYPERSTIMULATION SYNDROME; OVARY; OVULATION INDUCTION;

EID: 70350570070     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.08.129     Document Type: Article

References (21)

1. Geva E., and Jaffe R.B. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 74 (2000) 429-438
2. Navot D., Margalioth E.J., Laufer N., Birkenfeld A., Relou A., Rosler A., et al. Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome. Fertil Steril 48 (1987) 57-61
3. Senger D.R., Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey V.S., and Dvorak H.F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219 (1983) 983-985
4. Folkman J. Angiogenesis: an organizing principle for drug discovery?. Nat Rev Drug Discov 6 (2007) 273-286
5. Dvorak H.F. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 20 (2002) 4368-4380
6. Levin E.R., Rosen G.F., Cassidenti D.L., Yee B., Meldrum D., Wisot A., et al. Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome. J Clin Invest 102 (1998) 1978-1985
7. McClure N., Healy D.L., Rogers P.A., Sullivan J., Beaton L., Haning Jr. R.V., et al. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 344 (1994) 235-236
8. Neulen J., Yan Z., Raczek S., Weindel K., Keck C., Weich H.A., et al. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 80 (1995) 1967-1971
9. Golub L.M., Lee H.M., Ryan M.E., Giannobile W.V., Payne J., and Sorsa T. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 12 (1998) 12-26
10. Moses M.A., Harper J., and Folkman J. Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs. N Engl J Med 354 (2006) 2621-2622
11. Suomalainen K., Sorsa T., Golub L.M., Ramamurthy N., Lee H.M., Uitto V.J., et al. Specificity of the anticollagenase action of tetracyclines: relevance to their anti-inflammatory potential. Antimicrob Agents Chemother 36 (1992) 227-229
12. Fainaru O., Adini I., Benny O., Bazinet L., Pravda E., D'Amato R., et al. Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability. FASEB J (2008)
13. Miles A.A., and Miles E.M. Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea-pigs. J Physiol 118 (1952) 228-257
14. Prall A.K., Longo G.M., Mayhan W.G., Waltke E.A., Fleckten B., Thompson R.W., et al. Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice. J Vasc Surg 35 (2002) 923-929
15. Mathur R., Kailasam C., and Jenkins J. Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome. Hum Fertil (Camb) 10 (2007) 75-85
16. Ujioka T., Matsuura K., Kawano T., and Okamura H. Role of progesterone in capillary permeability in hyperstimulated rats. Hum Reprod 12 (1997) 1629-1634
17. Gomez R., Simon C., Remohi J., and Pellicer A. Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability. Biol Reprod 68 (2003) 2164-2171
18. Kitajima Y., Endo T., Manase K., Nishikawa A., Shibuya M., and Kudo R. Gonadotropin-releasing hormone agonist administration reduced vascular endothelial growth factor (VEGF), VEGF receptors, and vascular permeability of the ovaries of hyperstimulated rats. Fertil Steril 81 Suppl 1 (2004) 842-849
19. Rizk B., and Smitz J. Ovarian hyperstimulation syndrome after superovulation using GnRH agonists for IVF and related procedures. Hum Reprod 7 (1992) 320-327
20. Agwuh K.N., and MacGowan A. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J Antimicrob Chemother 58 (2006) 256-265
21. Hurst B.S., Tucker K.E., Awoniyi C.A., and Schlaff W.D. Hydrosalpinx treated with extended doxycycline does not compromise the success of in vitro fertilization. Fertil Steril 75 (2001) 1017-1019